Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Preveceutical Medical Inc (PRVCF)

Preveceutical Medical Inc (PRVCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
PreveCeutical Announces Management Cease Trade Order Newsfile - Thu May 2, 5:48PM CDT

Vancouver, British Columbia--(Newsfile Corp. - May 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the "Company" or "PreveCeutical") announces that the Company has missed...

PRVCF : 0.0130 (-10.34%)
PREV.CN : 0.0150 (-50.00%)
PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM Newswire.ca - Mon Dec 4, 2023

/CNW/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that it has started...

PREV.CN : 0.0150 (-50.00%)
PRVCF : 0.0130 (-10.34%)
PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application PR Newswire - Mon Sep 18, 2023

/PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is proud to announce that Endosane...

PREV.CN : 0.0150 (-50.00%)
PRVCF : 0.0130 (-10.34%)
PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application Newswire.ca - Mon Sep 18, 2023

/CNW/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is proud to announce that Endosane Pharmaceuticals...

PREV.CN : 0.0150 (-50.00%)
PRVCF : 0.0130 (-10.34%)
PreveCeutical Showcases Dynamic Evolution in AI Strategy Newswire.ca - Tue Sep 12, 2023

/CNW/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), PreveCeutical Medical Inc. marks today as an...

PREV.CN : 0.0150 (-50.00%)
PRVCF : 0.0130 (-10.34%)
PreveCeutical Showcases Dynamic Evolution in AI Strategy PR Newswire - Tue Sep 12, 2023

/PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), PreveCeutical Medical Inc. marks today as...

PREV.CN : 0.0150 (-50.00%)
PRVCF : 0.0130 (-10.34%)
PreveCeutical Engages New to the Street for Production & Broadcasting Services PR Newswire - Thu Aug 31, 2023

/PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), announces that it has entered into a...

PREV.CN : 0.0150 (-50.00%)
PRVCF : 0.0130 (-10.34%)
PreveCeutical Engages New to the Street for Production & Broadcasting Services Newswire.ca - Thu Aug 31, 2023

/CNW/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), announces that it has entered into a Service...

PREV.CN : 0.0150 (-50.00%)
PRVCF : 0.0130 (-10.34%)
PreveCeutical Files Cyclic Peptides And Uses Thereof in the EU and Australia PR Newswire - Mon Jul 24, 2023

/PRNewswire/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that PreveCeutical...

PREV.CN : 0.0150 (-50.00%)
PRVCF : 0.0130 (-10.34%)
PreveCeutical Files Cyclic Peptides And Uses Thereof in the EU and Australia Newswire.ca - Mon Jul 24, 2023

/CNW/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), is pleased to announce that PreveCeutical is...

PREV.CN : 0.0150 (-50.00%)
PRVCF : 0.0130 (-10.34%)

Barchart Exclusives

Is This Dividend Stock a Buy Now? Barchart - 1 hour ago
With a robust portfolio, this top pharma stock is a good mix of growth and income. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot